Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01420094 · ClinicalTrials.gov registry record · Phase 3
Evaluate Onset of Action of a Fast Release Aspirin
A Phase 3 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 510
- Enrollment target
NCT01420094: Completed Phase 3 study, sponsored by Bayer.
NCT01420094 is a Phase 3 study that has completed, run by Bayer. The registered enrollment target is 510 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01420094, a Phase 3 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 510 participants
- Enrollment target
Study Summary
To compare the safety and efficacy (onset, duration of relief and overall efficacy) of a single dose of a fast release formulation of aspirin 1000 mg compared to acetaminophen 1000 mg and placebo for relief of pain following extraction of impacted third molars.
Interventions
- DRUG Placebo
- DRUG Acetylsalicyclic acid (Fast release Aspirin, BAY1019036)
- DRUG Acetaminophen (Tylenol extra strength)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 510 participants |
| Start Date | 2011-06-16 |
| Est. Completion | 2011-09-08 |
| Phase | Phase 3 |
What the finished NCT01420094 record still lists
NCT01420094 is an interventional study that assigns participants to a tested intervention. The registered 510 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (34% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01420094 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01420094 about?
NCT01420094 is a clinical study titled "Evaluate Onset of Action of a Fast Release Aspirin". To compare the safety and efficacy (onset, duration of relief and overall efficacy) of a single dose of a fast release formulation of aspirin 1000 mg compared to acetaminophen 1000 mg and placebo for relief of pain following extraction of impacted third molars.
What is the current status of trial NCT01420094?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 510 participants. The study started on 2011-06-16. Estimated completion is 2011-09-08.
What interventions are being tested in trial NCT01420094?
The interventions under investigation include: Placebo (DRUG), Acetylsalicyclic acid (Fast release Aspirin, BAY1019036) (DRUG), Acetaminophen (Tylenol extra strength) (DRUG).
Who is sponsoring clinical trial NCT01420094?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01420094's enrollment target sits among peer trials
510 729th of 2000 higher than 1,264 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
- NCT04634552 · 510 participants · Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- NCT05164744 · 510 participants
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
- NCT05451004 · 510 participants · Phase 3
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI